Skip to content

Serotonin: all studies

Page 262 of 401: studies 2,611 to 2,620 of 4,004, newest first. Back to the serotonin overview

Research

Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.

Journal of Palliative Medicine October 1, 2023 Noah D Gold, Austin J. Mallard, Jacob C Hermann et al. 5 citations

Background: Amyotrophic lateral sclerosis (ALS) is an aggressive, terminal neurodegenerative disease that causes death of motor neurons and has an average survival time of 3-4 years. ALS is the most common motor neuron degenerative disease and is increasing in prevalence. There is a pressing need for more effective ALS treatments as available pharmacotherapies do not reverse disease progression...

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Neuropsychopharmacology October 1, 2023 Laura Ley, Friederike Holze, Denis Arikci et al. 127 citations

Mescaline, lysergic acid diethylamide (LSD), and psilocybin are classic serotonergic psychedelics. A valid, direct comparison of the effects of these substances is lacking. The main goal of the present study was to investigate potential pharmacological, physiological and phenomenological differences at psychoactive-equivalent doses of mescaline, LSD, and psilocybin. The present study used a...

DOI: 10.1038/s41386-023-01607-2 (opens in new tab) Full text (opens in new tab) Psychedelics Hallucinogens Comparative drug research Pharmacology

A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines.

Journal of Biological Chemistry October 1, 2023 Xue Chen, Jing Li, Lisa Yu et al. 13 citations

Psychedelic indolethylamines have emerged as potential medicines to treat several psychiatric pathologies. Natural sources of these compounds include 'magic mushrooms' (Psilocybe spp.), plants used to prepare ayahuasca, and toads. The skin and parotid glands of certain toads accumulate a variety of specialized metabolites including toxic guanidine alkaloids, lipophilic alkaloids, poisonous...

DOI: 10.1016/j.jbc.2023.105231 (opens in new tab) Full text (opens in new tab) N-methyltransferase Rhinella marina Drug discovery Enzyme kinetics +11

Use of Psychedelics for Pain: A Scoping Review.

Anesthesiology October 1, 2023 Akash Goel, Yeshith Rai, Shayan Sivadas et al. 29 citations

Chronic pain is a public health concern that affects approximately 1.5 billion people globally. Conventional therapeutic agents including opioid and non-opioid analgesics have been associated with adverse side effects, issues with addiction, and ineffective analgesia. Novel agents repurposed to treat pain via different mechanisms are needed to fill the therapeutic gap in chronic pain...

DOI: 10.1097/aln.0000000000004673 (opens in new tab) Full text (opens in new tab) Psychedelics Medical research Pain management Alternative medicine

Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.

Archives of Razi Institute October 1, 2023 Rajagopal Kalirajan, Khare Rishabh, Jupudi Srikanth et al.

Since depression is a common mental illness affecting an estimated 5% of people worldwide, investigators are encouraged to develop effective antidepressants. According to the monoamine-deficiency hypothesis, the underlying pathophysiology of depression is a deficiency of some neurotransmitters (serotonin, norepinephrine, or dopamine) in the central nervous system. The neurotransmitter serotonin...

Desenvolvimento de método baseado em Toxicologia Analítica Verde para determinação dos componentes ativos da ayahuasca em cabelo

September 27, 2023 Fabiana Pereira Santos

A ayahuasca é uma bebida alucinógena originária na América do Sul, utilizada por indígenas em rituais xamânicos. É obtida através da fermentação de duas plantas, a folha da P. viridis, na qual é obtida a dimetiltriptamina (DMT), substância responsável pelos efeitos alucinógenos e o cipó B. caapi que contém β-carbolinas (harmina, harmalina e tetraidro-harmina). As β-carbolinas impedem a...

A suite of engineered mice for interrogating psychedelic drug actions

bioRxiv (Cold Spring Harbor Laboratory) September 26, 2023 Yi-Ting Chiu, Wei Wang, Pierre Llorach et al. 15 citations preprint

ABSTRACT Psychedelic drugs like lysergic acid diethylamide (LSD) and psilocybin have emerged as potentially transformative therapeutics for many neuropsychiatric diseases, including depression, anxiety, post-traumatic stress disorder, migraine, and cluster headaches. LSD and psilocybin exert their psychedelic effects via activation of the 5-hydroxytryptamine 2A receptor (HTR2A). Here we provide...

From the party to the therapy – MDMA as an alternative for the existing methods of Post-traumatic Stress Disorder treatment

Current Problems of Psychiatry September 22, 2023 Wiktoria Bojarska, Karolina Bury, Radosław Januszczak et al.

Introduction: Post-traumatic Stress Disorder (PTSD) is a mental illness caused by exposure to a traumatic event. The current treatment includes trauma-focused psychotherapy along with selective serotonin reuptake inhibitors (SSRI). It is estimated that for about 40-60% of patients it does not bring the desired improvement, which prompted scientists to look for new methods of pharmacotherapy....

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression

Frontiers in Psychiatry September 19, 2023 Nicolas Garel, Jessica Drury, Julien Thibault Lévesque et al. 32 citations

Background Subanesthetic ketamine has accumulated meta-analytic evidence for rapid antidepressant effects in treatment-resistant depression (TRD), resulting in both excitement and debate. Many unanswered questions surround ketamine’s mechanisms of action and its integration into real-world psychiatric care, resulting in diverse utilizations that variously resemble electroconvulsive therapy,...

DOI: 10.3389/fpsyt.2023.1268832 (opens in new tab) Ketamine Biopsychosocial model Psychotherapist Clinical psychology

Psychoactive substances 25H-NBOMe and 25H-NBOH induce antidepressant-like behavior in male rats.

European Journal of Pharmacology September 15, 2023 Barbara G Ferri, Cintia O De Novais, Raquel S Bonani et al. 11 citations

Ring-substituted phenethylamines are believed to induce psychedelic effects primarily by interacting with 5-hydroxytryptamine 2 (5-HT2A) receptors in the brain. We assessed the effect of the psychedelic substances 25H-NBOMe and 25H-NBOH on the depressive-like behavior of male adult rats. Naive Wistar rats were divided into groups to assess the effects of different doses (0.1 mg/kg, 1 mg/kg, and...